Loading provider…
Loading provider…
Allergy & Immunology Physician in Scottsdale, AZ
NPI: 1396744249Primary Employer
Allergy, Asthma & Immunology Associates Ltd
allergyasthmaaz.com
HQ Phone
Get MD Michael's Phone Numberphone_androidMobile
Get MD Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAZ State Medical License
TX State Medical License
1988
CA State Medical License
1989 - 2027
AZ State Medical License
1987 - 2026

American Board of Allergy and Immunology
Allergy & Immunology

American Board of Internal Medicine
Internal Medicine
Scripps Clinic/Scripps Green Hospital
Fellowship • Allergy and Immunology
1989 - 1991
McGovern Medical School
med.uth.edu
Medical School
Until 1986
Creighton University School of Medicine - Omaha
creighton.edu
Residency • Internal Medicine
1986 - 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 95117Injection of incremental dosages of allergen, 2 or more injections | 463 | 4,245 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 429 | 564 |
| 3 | 95165Preparation and provision of single or multiple antigens for allergen immunotherapy | 344 | 4,645 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 148 | 148 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 139 | 1,441 |
Authors: Jonathan Bernstein, Timothy Craig, Michael Manning, Jonathan Bernstein
Journal: Allergy Asthma Clin Immunol
Publication Date: 2025-03-15
Authors: Marc Riedl, Jonathan Bernstein, Timothy Craig, William Lumry, Raffi Tachdjian, John Anderson, Jonathan Bernstein
Journal: Allergy Asthma Clin Immunol
Publication Date: 2023-12-11
Lead Sponsor: CSL Behring
Intervention / Treatment: BIOLOGICAL: CSL312
Lead Sponsor: Shire
Collaborators: Dyax Corp.
Intervention / Treatment: DRUG: Placebo, DRUG: DX-2930 - 300mg/2wk, DRUG: DX-2930 - 300mg/4wk, DRUG: DX-2930 - 150mg/4wk